New York, NY -- (SBWIRE) -- 08/21/2018 -- The single-cell analysis market size is projected to reach $5.3 billion by 2022, growing at a CAGR of 18.1% between 2016-2022. The market is driven by factors such as increasing healthcare expenditure, growing geriatric population, high prevalence of infectious diseases, technological advancements in single-cell analysis products, and growing focus on personalized medicines.

Get a Sample Copy of This Report at: https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market/report-sample

In terms of the type of product, the single-cell analysis market has been segmented into consumables and instruments. The single-cell analysis consumables segment accounted for the major share in the global market in 2015, and it is expected to witness the highest growth during 2016-2022.

In terms of the type of cell, the single-cell analysis market has been segmented into human cell, animal cell, and microbial cell. The human cell segment accounted for the major share in the worldwide market in 2015, and it is expected to witness the highest growth during 2016-2022.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=single-cell-analysis-market

In terms of the type of technique, the single-cell analysis market has been segmented into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), microscopy, and others (mass spectrometry, and laser capture microdissection). The flow cytometry segment accounted for the major share in the global market in 2015, and NGS is expected to witness the highest growth during 2016-2022.

In terms of application, the single-cell analysis market has been segmented into research application and diagnostic application. The research application segment accounted for the major share in the worldwide market in 2015, and is expected to witness the highest growth during 2016-2022.

Browse report at: https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market

In terms of end user, the single-cell analysis market has been segmented into hospitals, biotechnology companies, research institute, and cell banks and IVF Centers. The hospitals segment accounted for the major share in the worldwide market in 2015, and it is expected to witness the highest growth during 2016-2022.

Competitive Analysis

Some of the key companies operating in the single-cell analysis market include Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Nanostring technologies, Agilent Technologies, Fluidigm Corporation.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.